Google Alert - pharmaceutical news

News 8 new results for pharmaceutical news

Budeprion XL 300: Defective Generic Drug Revives Quality Concerns Huffington Post Developing and testing an original prescription drug can take more than a decade and cost upwards of $1 billion dollars, according to the Pharmaceutical Research and Manufacturers Association. The high price tag on most new drugs reflects the cost of ... See all stories on this topic »

Collegium Pharmaceutical to Present at 11th Annual BIO Investor Forum The Herald | HeraldOnline.com CUMBERLAND, R.I. — Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce that Michael Heffernan, President and CEO of Collegium, will present a ... See all stories on this topic »

Ohr Pharmaceutical to Present at the 11th Annual BIO Investor Forum Equities.com NEW YORK, Oct. 5, 2012 /PRNewswire/ -- Ohr Pharmaceutical (OTCBB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, announced today that Dr. Irach Taraporewala, Chief Executive ... See all stories on this topic »

Japanese firm buys Montana pharmaceutical company U.S. News & World Report (AP) — A Japanese pharmaceutical company has purchased Bozeman-based LigoCyte Pharmaceuticals in a $60 million deal. The executive vice president of Takeda Pharmaceutical Co.'s vaccine business division, Rajeev Venkayya, says LigoCyte's work ... See all stories on this topic »

Bitter pill: Regulator cracks down on overpriced drugs Hindustan Times The drug regulator has stepped up its crackdown against major pharmaceutical companies have been cocking a snook at the government and selling regulated drugs at higher than stipulated prices. The National Pharmaceutical Pricing Authority (NPPA) has ... See all stories on this topic »

ScripsAmerica Announces Shipment of First Order by Acquisition Target Marlex ... NASDAQ "The shipment and invoicing of Marlex's first pharmaceutical order to the Department of Defense marks the official start of a multi-year contract, representing a significant milestone for the company. We are very excited by this development and look ... See all stories on this topic »

Mistrust puts pharmaceutical industry in the spotlight EurActiv SPECIAL REPORT / The European healthcare system is struggling to cope with low levels of transparency and trust in the pharmaceutical sector, according to 97% of doctors, industry professionals and policymakers attending a workshop at the Gastein ... See all stories on this topic » EurActiv

Investors, Take A Look At This Global Pharmaceutical Company The motley Fool (blog) This will be a good news for big pharmaceutical companies, because each and every year they spend millions, or even billions, for testing and applying their medicines to get on pharmacy shelves and physician's prescription pads. When successful, a ... See all stories on this topic » The motley Fool (blog)

---

Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.